BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 32283497)

  • 1. Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.
    Ghosh A; Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(4):273-276. PubMed ID: 32283497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter to the editor in response to: Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.
    Vaishya R; Bahl S; Singh RP
    Diabetes Metab Syndr; 2020; 14(4):687-688. PubMed ID: 32442918
    [No Abstract]   [Full Text] [Related]  

  • 3. Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them.
    Iyengar K; Jain VK; Vaishya R
    Diabetes Metab Syndr; 2020; 14(5):797-799. PubMed ID: 32534432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teleconsultation and Diabetes Care Amid COVID-19 Pandemic in India: Scopes and Challenges.
    Banerjee M; Chakraborty S; Pal R
    J Diabetes Sci Technol; 2020 Jul; 14(4):714-715. PubMed ID: 32438820
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil.
    Teles M; Sacchetta T; Matsumoto Y
    J Diabetes Sci Technol; 2020 Jul; 14(4):797-798. PubMed ID: 32482098
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes self-management amid COVID-19 pandemic.
    Banerjee M; Chakraborty S; Pal R
    Diabetes Metab Syndr; 2020; 14(4):351-354. PubMed ID: 32311652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic.
    Ghosh A; Dutta K; Tyagi K; Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(4):577-578. PubMed ID: 32416526
    [No Abstract]   [Full Text] [Related]  

  • 8. Telemedicine for Diabetes After the COVID-19 Pandemic: We Can't Put the Toothpaste Back in the Tube or Turn Back the Clock.
    Klonoff DC
    J Diabetes Sci Technol; 2020 Jul; 14(4):741-742. PubMed ID: 32506942
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 pandemic and challenges for socio-economic issues, healthcare and National Health Programs in India.
    Gopalan HS; Misra A
    Diabetes Metab Syndr; 2020; 14(5):757-759. PubMed ID: 32504992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the Editor: Endocrine and diabetes clinical practice during national lockdown and post lockdown period.
    Panchangam RB; Kota SK; Mayilvaganan S
    Diabetes Metab Syndr; 2020; 14(4):479. PubMed ID: 32387866
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes care during COVID-19 lockdown at a tertiary care centre in India.
    Joshi R; Atal S; Fatima Z; Balakrishnan S; Sharma S; Joshi A
    Diabetes Res Clin Pract; 2020 Aug; 166():108316. PubMed ID: 32673697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Telemedicine During the COVID-19 Pandemic.
    Mahajan V; Singh T; Azad C
    Indian Pediatr; 2020 Jul; 57(7):652-657. PubMed ID: 32412914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of eHealth for the Care of Patients With Diabetes in Connection to the COVID-19 Pandemic.
    Jendle J
    J Diabetes Sci Technol; 2020 Jul; 14(4):739-740. PubMed ID: 32375494
    [No Abstract]   [Full Text] [Related]  

  • 14. Teledentistry during COVID-19 pandemic.
    Ghai S
    Diabetes Metab Syndr; 2020; 14(5):933-935. PubMed ID: 32593116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and applications of smartphone technology in the current pandemic.
    Iyengar K; Upadhyaya GK; Vaishya R; Jain V
    Diabetes Metab Syndr; 2020; 14(5):733-737. PubMed ID: 32497963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.
    Singh AK; Gupta R; Ghosh A; Misra A
    Diabetes Metab Syndr; 2020; 14(4):303-310. PubMed ID: 32298981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telemedicine During the COVID-19 Crisis and Beyond.
    Blevins T; Ozer K
    Tex Med; 2020 Jul; 116(7):4-5. PubMed ID: 32872703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefining diabetic foot disease management service during COVID-19 pandemic.
    Jaly I; Iyengar K; Bahl S; Hughes T; Vaishya R
    Diabetes Metab Syndr; 2020; 14(5):833-838. PubMed ID: 32540738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caring for a child with type 1 diabetes during COVID-19 lockdown in a developing country: Challenges and parents' perspectives on the use of telemedicine.
    Odeh R; Gharaibeh L; Daher A; Kussad S; Alassaf A
    Diabetes Res Clin Pract; 2020 Oct; 168():108393. PubMed ID: 32858098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of COVID-19 related lockdown on ophthalmic practice and patient care in India: Results of a survey.
    Nair AG; Gandhi RA; Natarajan S
    Indian J Ophthalmol; 2020 May; 68(5):725-730. PubMed ID: 32317434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.